Priced at $17, raising $289 million
Attovia raised $289 million, one of the largest biotech raises in a year of scarce deals. Morgan Stanley, Leerink, Citigroup and RBC ran the books, giving the multispecific antibody developer a fully funded shot at public markets.
Source: SEC filing